Expansion of Newborn Screening by G-BA Set for 2026

The Gemeinsame Bundesausschuss (G-BA), Germany's top healthcare decision-making body, announced on May 15 that starting in 2026, newborns will be screened for three additional rare genetic disorders as well as Vitamin B12 deficiency.

This expansion aims to identify conditions that, if left untreated, could lead to severe physical and cognitive developmental issues. The new screening will include tests for Homocystinuria, Propionic Acidemia, and Methylmalonic Acidemia, alongside Vitamin B12 deficiency, which is crucial for the child's health.

The screening process involves taking a few drops of blood from the newborn's heel on their second or third day of life. The blood is collected on a filter paper card and sent to a laboratory for analysis. If the results are normal, parents will not be contacted further. However, in the case of abnormal results, parents will receive a direct follow-up from the laboratory within 72 hours, initiating further diagnostic procedures often at specialized centers.

Particularly noteworthy is the inclusion of Vitamin B12 deficiency in the screening protocol. This deficiency can be either genetic or acquired, such as from maternal Vitamin B12 deficiency during pregnancy, which is often linked to vegetarian or vegan diets. Untreated, Vitamin B12 deficiency can result in anemia and developmental delays in infants, but it is manageable through short-term supplementation; in cases of genetic origins, lifelong supplementation may be required.

The three newly included metabolic disorders in the screening are rare but can have serious consequences. Homocystinuria encompasses a group of genetic conditions characterized by elevated levels of homocysteine in the blood and urine, potentially leading to developmental delays, vision problems, and seizures. Propionic Acidemia and Methylmalonic Acidemia are metabolic disorders that can cause complications such as heart disease, developmental issues, and kidney insufficiency. Treatment strategies often involve specialized diets to prevent metabolic crises.